NAD+ likely plays a critical role in tumorigenesis, as depletion of intracellular NAD+ levels by inhibition of NAMPT can impair prostate cancer cell proliferation [32], a result that we reproduced in our study. The gene discussed is NAMPT; the disease is Familial prostate cancer.